Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-03-03 @ 12:02 AM
Study NCT ID:
NCT02732327
Status:
TERMINATED
Last Update Posted:
2017-07-21
First Post:
2016-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Sponsor:
Forest Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-18
First Submit QC Date:
None
Study First Post Date:
2016-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-06-22
Results First Submit QC Date:
None
Results First Post Date:
2017-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-22
Last Update Post Date:
2017-07-21
Last Update Post Date Type:
ACTUAL